A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2004
12/29/2004	WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
12/29/2004	WO2003031569A3 Nucleic acid vaccines using tumor antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acid
12/29/2004	WO2003025200A3 Methods of using 22417, a novel human aminoprotease family member
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
12/29/2004	EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
12/29/2004	EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
12/29/2004	EP1491193A1 Therapeutic combinations comprising amlodipine and atorvastatin
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
12/29/2004	EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490519A2 Life sciences business systems and methods
12/29/2004	EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21
12/29/2004	EP1490494A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
12/29/2004	EP1490473A1 Bacterial spores
12/29/2004	EP1490409A1 Modified saccharides having improved stability in water
12/29/2004	EP1490407A1 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
12/29/2004	EP1490406A1 Costimulatory molecule and its use
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490398A2 Tumour associated antigens
12/29/2004	EP1490396A2 Immunogenic hiv peptides for use as reagents and vaccines
12/29/2004	EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
12/29/2004	EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
12/29/2004	EP1490387A2 A human ribonucleotide reductase m2 subunit
12/29/2004	EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004	EP1490110A2 Anti-alpha v beta 6 antibodies
12/29/2004	EP1490109A2 Egfr ligands and methods of use
12/29/2004	EP1490107A1 Modulating angiogenesis
12/29/2004	EP1490106A2 Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations
12/29/2004	EP1490105A2 Multiple and multivalent dna vaccines in ovo
12/29/2004	EP1490104A2 Protein-based streptococcus pneumoniae vaccines
12/29/2004	EP1490103A2 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthama(obstructive lung disease)
12/29/2004	EP1490102A1 Fuel additive
12/29/2004	EP1490101A1 Methods of enhancing immune induction involving mda-7
12/29/2004	EP1490100A2 Combined dna/protein vaccine compositions
12/29/2004	EP1490099A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
12/29/2004	EP1490098A2 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
12/29/2004	EP1490094A1 Antibody fusion proteins: effective adjuvants of protein vaccination
12/29/2004	EP1490086A2 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
12/29/2004	EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004	EP1490083A1 Microgel particles for the delivery of bioactive materials
12/29/2004	EP1295606A4 Curing method for pathologic syndrome and a medicinal preparation
12/29/2004	EP1287827B1 Immunopotentiator
12/29/2004	EP1284998B1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
12/29/2004	EP1218037B1 In vivo assay for testing the phenotypic stability
12/29/2004	EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004	EP1124576B1 Method for preparing solid phase conjugate vaccines
12/29/2004	EP1090033B1 Particles of hcv envelope proteins: use for vaccination
12/29/2004	EP1084251B1 Attenuated pestiviruses
12/29/2004	EP1066375B1 $i(LACTOBACILLI) HARBORING AGGREGATION AND MUCIN BINDING GENES AS VACCINE DELIVERY VEHICLES
12/29/2004	EP1011720B1 Mucosal cytotoxic t lymphocyte responses
12/29/2004	EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS
12/29/2004	EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004	EP0626008B1 Vaccine containing acemannan as an adjuvant
12/29/2004	EP0623172B1 Marek's disease virus recombinant vaccinia virus vaccine
12/29/2004	CN1558915A Leukocyte inactivation module
12/29/2004	CN1558914A Receptor, the use thereof, and mouse antibodies
12/29/2004	CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004	CN1558774A Angiotensin peptide-carrier conjugates and uses thereof
12/29/2004	CN1558763A Treatment of hepatitis B virus infection with human monoclonal antibodies
12/29/2004	CN1557954A Expression and application of transduction peptides - human insulinogen fusion protein
12/29/2004	CN1557837A Process for preparing multi-bioactive substances from cattle colostrum
12/29/2004	CN1557836A Preparation and use for immunosuppressive polypeptides
12/29/2004	CN1557494A Preparation of microorganism resisting biological active component and its application
12/29/2004	CN1557493A Specific antibody for preventing and treating periodontal disease
12/29/2004	CN1557492A Helicobacter Pylori resisting specific immune globulin preparation
12/29/2004	CN1557491A Specific antibody preparation for inhibiting decayed tooth bacteria
12/29/2004	CN1557490A Microorganism infection resisting immune globulin
12/29/2004	CN1557489A Preparation of oral administered immune globulin from whey
12/29/2004	CN1557488A Preparation for treating intractable chronic pain and its preparing process
12/29/2004	CN1557487A Immunogenicity composition for preventing and treating diseases and its preparation
12/29/2004	CN1557486A Bivalent DNA vaccine of type A and type O foot-and-mouth disease virus and its preparing process
12/29/2004	CN1557468A Preparation method and application of antiphlogistic factor
12/29/2004	CN1557340A Growth factor and immuneglobin preparation
12/29/2004	CN1557339A Preparation for preventing and treating tympanitis and dental caries
12/29/2004	CN1557338A Preparation for preventing and treating rheumatic arthritis and other autoimmune disease
12/29/2004	CN1557336A Cardiovascular and respiratory function regulating biological active prescription
12/29/2004	CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine
12/29/2004	CA2530214A1 Cancerous disease modifying antibodies
12/29/2004	CA2529997A1 Novel surface protein (hbsag) variant of hepatitis b virus
12/29/2004	CA2529986A1 Novel surface protein (hbsag) variant of hepatitis b virus
12/29/2004	CA2529565A1 Modified bordetella adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof
12/29/2004	CA2529056A1 Combinations of tumor-associated antigens in compositions for various types of cancers
12/29/2004	CA2529051A1 Vaccines, immunotherapeutics and methods for using the same
12/29/2004	CA2528599A1 Proton-sensing g-protein coupled receptors and dna sequences thereof
12/29/2004	CA2527091A1 Interferon gamma-like protein
12/29/2004	CA2526647A1 Anti alpha - folate - receptor - tetramer antibodies
12/29/2004	CA2526640A1 Immunogenic reagents from west nile virus
12/29/2004	CA2524567A1 Compositions and methods for the diagnosis and treatment of tumors of glial origin
12/28/2004	US6835824 Peanut allergens and methods
12/28/2004	US6835822 Diagnosis and therapy of cancer using SGP28-related molecules
12/28/2004	US6835818 Mutants of Streptococcal toxin C and methods of use
12/28/2004	US6835817 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
12/28/2004	US6835721 Phosphate or ammonium compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases
12/28/2004	US6835715 Mammalian dihydroouabain-like factor and therapeutic compositions
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	US6835564 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same

1 ... 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 ... 1823